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Baccharis dracunculifolia DC (Asteraceae) is a Brazilian medicinal plant popularly used for its antiulcer and anti-inﬂammatory
properties. This plant is the main botanical source of Brazilian green propolis, a natural product incorporated into food and
beverages to improve health. The present study aimed to investigate the chemical proﬁle and intestinal anti-inﬂammatory activity
of B. dracunculifolia extract on experimental ulcerative colitis induced by trinitrobenzenosulfonic acid (TNBS). Colonic damage
was evaluated macroscopically and biochemically through its evaluation of glutathione content and its myeloperoxidase (MPO)
and alkaline phosphatase activities. Additional in vitro experiments were performed in order to test the antioxidant activity by
inhibition of induced lipid peroxidation in the rat brain membrane. Phytochemical analysis was performed by HPLC using
authentic standards. The administration of plant extract (5 and 50mgkg−1) signiﬁcantly attenuated the colonic damage induced
by TNBS as evidenced both macroscopically and biochemically. This beneﬁcial eﬀect can be associated with an improvement in
the colonic oxidative status, since plant extract prevented glutathione depletion, inhibited lipid peroxidation and reduced MPO
activity. Caﬀeic acid, p-coumaric acid, aromadendrin-4-O-methyl ether, 3-prenyl-p-coumaric acid, 3,5-diprenyl-p-coumaric acid
and baccharin were detected in the plant extract.
1.Introduction
The inﬂammatory bowel diseases (IBD) refer essentially to
two diﬀerent but closely related conditions, Crohn’s disease
and ulcerative colitis. Although the etiology of IBD remains
unclear, there is evidence that it involves immune, genetic
and environmental factors, which are, in turn, related to the
initiation and progression of colitis [1, 2]. IBD is related to
an abnormally exacerbated immune response to otherwise
innocuous stimuli which is not properly abrogated by the
feedback system that normally downregulates the mucosal
response to luminal factors [3]. As a consequence, increased
numbers of inﬂammatory cells are found in areas of intestine
with chronic inﬂammation, resulting in overproduction of
variety ofproinﬂammatory mediators includingeicosanoids,
platelet-activating factor, cytokines and reactive oxygen and
nitrogen metabolites [1–4]. The oxidative stress through
an excessive release of reactive oxygen species has been
hypothesized to play a key role in IBD pathogenesis [5, 6]. In
fact,antioxidantactivitymayberesponsibleforthebeneﬁcial
eﬀects shown by 5-aminosalicylates in human IBD [7]
and for beneﬁts derived from diﬀerent natural compounds
in experimental models, mainly phenolic compounds as
ﬂavonoids [8], tempol [9], isocoumarin [10]a n dc o u m a r i n
derivatives [11].
Baccharis dracunculifolia DC (Asteraceae) is a Brazilian
medicinal shrub popularly known as “Alecrim do Campo”
thatisusedagainst ulcer,inﬂammation andhepaticdisorders
[12, 13]. This medicinal plant was found to be the main
botanical source of resin and chemical constituents of
Brazilian propolis, denominated green propolis, which was
recently incorporated into food and beverages to improve
health and to prevent several diseases [14–16].
In recent years, there has been growing interest in
studying the chemical proﬁle and biological activity of
Brazilian green propolis and its main botanical source, B.2 Evidence-Based Complementary and Alternative Medicine
dracunculifolia. Several studies have identiﬁed B. dracunculi-
folia as an important source of active compounds with try-
panocidal [17], antiulcer [18], antimicrobial [19], antimu-
tagenic [20], immunomodulatory [21], anti-inﬂammatory
[22] and radical scavenging [23] activities. Although green
propolis composition is more complex and unpredictable
thanpreviouslyassumed[24],itisclearthatpharmacological
potentialities of green propolis are related to substances
previously known as plant constituents, mainly from B.
dracunculifolia [14, 16, 24–26].
Therefore, the present work aimed to evaluate the
intestinal anti-inﬂammatory activity of ethyl acetate extract
from aerial parts of B. dracunculifolia in the trinitroben-
zenesulfonic (TNBS) acid model of rat colitis. For this
purpose, we assayed the eﬀects of B. dracunculifolia extract
in preventing the inﬂammatory response induced by TNBS
in two diﬀerent experimental settings, that is, when the
colonic mucosa is intact and when the mucosa is healing
after an initial insult. Thus, the present work also sought to
determine the chemical constituents of the B. dracunculifolia
ethyl acetate extract through HPLC analysis.
2.Methods
2.1. Preparation of Plant Extract. The aerial parts of B.
dracunculifolia DC were collected in Cajuru city, State of
S˜ ao Paulo, Brazil, in December 2005. The plant material
was authenticated by Jimi N. Nakagima, and a voucher
specimen (SPFR 06143) was deposited in the Herbarium
of the Biology Department of the University of S˜ ao Paulo
(FFCLRP) at Ribeir˜ ao Preto, State of S˜ ao Paulo, Brazil. Fresh
plantmaterial wasair-dried at40◦Cfor48h.Thedriedleaves
were powdered in a blender and submitted to maceration
for 24h in ethyl acetate at room temperature. This solvent
was used due to its polyphenolic content. After solvent
evaporation using vacuum < 40
◦C, an ethyl acetate extract
of B. dracunculifolia was obtained.
2.2. Experimental Design. Male Wistar rats (200±20g)
obtained from the Laboratory Animal Service of the S˜ ao
Paulo State University (UNESP) were randomly distributed
in experimental groups. The study was carried out in
accordance with “Guide for the Care and Use of Laboratory
Animals” as promulgated by the Animal Experimental
Committee of S˜ ao Paulo State University (protocol num-
ber 042/04-CEEA-IB). Animals were housed in makrolon
cages and maintained in air-conditioned with a 12h light-
dark cycle and air-ﬁltration, and they were provided with
free access to tap water and food. Colitis was induced
by the method originally described [27]. Animals were
fasted overnight and anaesthetized with halothane. Under
anaesthesia, they were given 10mg of TNBS dissolved in
0.25ml 50% ethanol (v/v) by means of a Teﬂon cannula
inserted 8cm through the anus. Rats from the non-colitic
group received 0.25ml of saline.
2.2.1. Acute Colitis. Rats were given 5, 10, 25, 50, 100 and
200mgkg−1 per day of B. dracunculifolia extract for 72, 48,
Table 1: Criteria for assessmentof macroscopic colonic damage
Score Criteria
0 No damage
1 Hyperemia, no ulcers
2 Linear ulcer with no signiﬁcant inﬂammation
3 Linear ulcer with inﬂammationat one site
4 Two or more sites of ulceration/inﬂammation
5
Two or more major sites of ulceration and
inﬂammationor one site of ulceration/inﬂammation
extending >1 cm along the length of the colon
6–10
If damage covers >2 cm along the length of the colon,
the score is increased by 1 for each additional
centimeter of involvement
24 and 2h before colitis induction as well as 24h thereafter.
The plant extract was suspended in 1% (v/v) Tween 80
and administered by means of an oesophageal catheter. Rats
from the non-colitic group were orally administered with
the saline and rats non-treated colitic (TNBS-control group)
with the vehicle (1% Tween 80). Animals from all groups (n
= 6) were killed 48h after colitis induction.
2.2.2. Chronic Colitis. In this protocol, colitis was induced
with 10mg ofTNBSin50%ethanol, as previouslydescribed.
The animals were divided in three groups; two groups were
daily orally treated with 5 and 50mgkg−1 of plant extract,
one group received instead 25mgkg−1 of sulfasalazine
suspended in the same vehicle. Treatments started 2h after
the ﬁrst administration of TNBS and continued until the
day before the animals were killed. Two additional groups
were included for reference: a non-colitic group and a colitic
group, receiving the latteronly the ﬁrst dose of TNBS(TNBS
control group). The animals of these groups were given the
vehicle (5ml kg−1 1% Tween 80) orally. Animals from each
group were killed after 1 or 2 weeks of the colitis induction.
2.2.3. Assessment of Colonic Damage. Animal body weights,
occurrence of diarrhoea and adherence of adjacent organs
were recorded. The animals were euthanized by an over-
dose of halothane, and colonic segments were obtained
after laparotomy. Colon were placed on an ice-cold plate,
cleaned of fat and mesentery, and blotted on ﬁlter paper,
weighed and its length measured under a constant load
(2g). The colon was longitudinally opened and scored for
macroscopically visible damage on a 0–10 scale by two
observers unaware of the treatment, according to the criteria
described [28]i nT a b l e1. The colon was subsequently
divided longitudinally into diﬀerent pieces to be used for
the biochemical determinations: total glutathione (GSH)
content [29], myeloperoxidase (MPO) activity [30]a n d
alkaline phosphatase (AP) activity [31].
Additional in vitro experiments were performed in order
to test the antioxidant activity of diﬀerent concentrations of
the ethyl acetate of B. dracunculifolia (12.5–1600 μgml −1).
These were evaluated by the assay of lipid peroxidation
in the rat brain membrane modiﬁed from the originalEvidence-Based Complementary and Alternative Medicine 3
protocol [32]. Brieﬂy, rat brain samples were obtained from
4-month-old male Wistar rats. All samples were diluted
upto 1:10 (w/v) in a buﬀer containing (mmol l−1)T r i s
50.0, NaCl 100, KCl 0.5, CaCl2 0.5, MgSO4 1.0, KH2PO4
0.55 and sucrose (pH 7.4) for preparation of a membrane-
enriched fraction. This membrane concentrationwas diluted
upto 1:4 v/v in the above-mentioned buﬀer solution but
with 20 mol l−1 Tris. Then, buﬀer (in the assays without
inhibitors) or diﬀerent concentrations of plant extract were
added. Lipid peroxidation was induced via nonenzymatic
way with 100μmo ll −1 of both ferrous sulfate and ascorbic
acid. After incubation at 37
◦Cf o r4 5m i n ,t h er e a c t i o nw a s
stopped and malondialdehyde (MDA) was analysed using
0.5% thiobarbituric acid in 20% trichloroacetic acid. The
amount of MDA produced after agitation, incubation at
100
◦C for 15min and centrifugation at 1000g for 15min at
4◦C, was determined by measuring the spectrophotometric
absorbance of the supernatant at 532nm. The ﬂavonoid
quercetin was used as reference and tested in the same assay
system.
2.3. Statistical Analysis. All results are expressed as the
mean±SEM. Diﬀerences between means were tested for
statistical signiﬁcance using one-way analysis of variance
(ANOVA) and post hoc least signiﬁcance tests. Nonparamet-
ric data (score) are expressed as median (range) and were
analysed with the Kruskal–Wallis test. Statistical signiﬁcance
was set at P < .05.
2.4. Phytochemical Analysis of Plant Extract by HPLC. The
ethyl acetate extract of the aerial parts from B. dracunculi-
folia was submitted to HPLC analysis using the following
equipment and conditions: a Shimadzu high performance
liquid-chromatograph (SCL-10Avp system controller, three
LC-10AD pumps, SPD-M10Avp photodiode array detector
and Shimadzu Class-VP 5.02 software). A CLC-ODS (M)
column (4.6mm i.d. × 250mm, 5μm particle diameter) and
a CLC G-ODS guard column were used as the stationary
phase. The mobile phase had the following composition: A–
B: 25–100% (B) in 60min, A: 93.9% water, 0.8% acetic acid,
0.3% ammonium acetate, 5.0% methanol; B: acetonitrile;
detection: 280 nm, ﬂow rate of 1ml min−1.T h ec o m p o u n d s
detected were identiﬁed by comparison with authentic
standards available, comparing UV spectra and considering
both the maximum lambda and the relative area obtained
with the use of two wavelengths (A280/320). The ethyl
acetate extract was dissolved in methanol (HPLC grade)
to obtain a concentration of 1mgml−1. Before analysis, all
samples were centrifuged at 1300 rpm and ﬁltered through a
45μmﬁ l t e r .
3.Results
Administration of TNBS/ethanol resulted in colonic inﬂam-
mation that presented several mucosal necrosis extending
along the colon accompanied by bowel wall thickening,
hyperemia and focal adhesions to adjacent organs (Table 2).
This inﬂammatory process was associated with an increase
of the colonic weight/length ratio and with signs of diarrhea
in 80% of the colitic animals (Table 2). In addition, the
colonic MPO and AP activities increased by 8-fold and 2-
fold, respectively, whereas glutathione levels were reduced by
56% in comparison with non-colitic rats (Table 3).
Oral administration of the plant extract at the doses of
5a n d5 0 m g k g −1 signiﬁcantly attenuated the macroscopic
mucosal damage in the TNBS/ethanol model of colitis in
rats (Table 2). Administration of 5mgkg−1 of the B. dracun-
culifolia extract to colitic animals was able to counteract the
colonic glutathione depletion that took place as a result of
the colonic oxidative damage induced by TNBS (Table 3).
Colonic tissue’s MPO activity diﬀered signiﬁcantly between
controls and treated colitic rats at the doses 5, 50, 100
and 200mgkg−1 (Table 3). AP activity was also reduced in
rats treated with 50mgkg−1 of plant extract. The eﬀects of
plant extract were similar to those produced by sulfasalazine
(Tables2 and 3). These resultsprompt usto select bothdoses
(5 and 50mgkg−1) for testing with the chronic protocol.
In the chronic colitis, the inﬂammatory process induced
by intracolonic instillation of 10mg ofTNBS in 50% ethanol
(v/v) progressed over time with characteristics similar to
those previously reported [10, 11]. Indeed, an alteration of
the colonic absorptive function was noted since 67% of rats
evidenced signs of diarrhea (Table 4).
Administration of 5 and 50mgkg−1 of B. dracunculifolia
extract tocoliticanimals reduceddamage score,lesionexten-
sion, diarrhoea signs and adherence of colon to adjacent
organs after the ﬁrst week (Table 4). Thus, both doses of B.
dracunculifolia extract were able to counteract GSH content
and to reduce MPO and AP activities by the end of the ﬁrst
week (Table 5). After 2 weeks, both doses of plant extract
were actively counteracting the GSH content and reducing
AP activity (Table 5).
The in vitro experiments performed showed that the
plant extract exerts an inhibitory eﬀect on the lipid peroxi-
dation induced in rat brain membranes, with an IC50 value
of 26.33 μgml −1.T h ec o r r e s p o n d i n gI C 50 value of quercetin
was 1.51μm corresponding to 0.46 μgml −1.
HPLC analysis of the ethyl acetate extract of B. dracun-
culifolia permitted the identiﬁcation of only the following
compounds: caﬀeic acid, p-coumaric acid, aromadendrin-
4-O-methyl ether, 3-prenyl-p-coumaric acid, 3,5-diprenyl-p-
coumaric acid and baccharin (Figures 1 and 2).
4.Discussion
The role of reactive metabolites of oxygen and nitrogen
in the pathophysiology of IBD has been well reported in
humans as experimental models of colitis [6, 10, 33, 34].
Theinﬂammatory processintheintestineisprobablyderived
from the chronic presence of numerous, activated, MPO-
containing phagocytes in the inﬂamed intestine. These are
responsible forthe overproductionofreactive oxygenspecies
thatoverwhelm theantioxidantdefences,suchas glutathione
and itsrelatedenzymesthatnormally participlein protecting
colonic tissue from oxidative damage. In fact, it has been
reported that the production of reactive oxygen species is4 Evidence-Based Complementary and Alternative Medicine
Table 2: Eﬀects of B. dracunculifolia extract (5–200mgkg−1) and sulfasalazine (25mgkg−1) on damage score, changes in colonic
weight/length, diarrhea and adherence incidence in TNBS acute colitis
Group Damage
scorea (0–10)
Colonic
weight/lengthb
(mg cm−1)
Diarrhoea (%) Adherence (%)
Non-colitic 0∗∗∗ 82.30±3.86∗∗ 00
TNBS-control 8.5 (7–9) 146.99±8.78 80.0 50.0
B. dracunculifolia
5mgkg −1 6.0 (5–8)∗ 127.44±8.06 50.0 50.0
10mgkg−1 7.5 (6–8) 127.82±3.94 50.0 66.7
25mgkg−1 7.5 (5–10) 135.28±6.33 66.7 66.7
50mgkg−1 6.5 (5–8)∗ 139.10±9.05 33.3∗ 0∗
100mgkg−1 6.5 (4–8) 131.53±7.34 83.3 33.3
200mgkg−1 7.0 (4–8) 134.62±9.11 50.0 33.3
Sulfasalazine 6.0 (2–8)∗∗ 133.58±12.38 16.7 50.0
aScore data are expressed as median (range).
bColonic weight data are expressed as mean±SEM.
∗P < .05; ∗∗P < .01; ∗∗∗P < .001 versus TNBS control group.
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Figure 1: Structures of chemical constituents in the ethyl acetate extract of B. dracunculifolia.( 1)c a ﬀeic acid; (2) p-coumaric acid; (3)
aromadendrin-4-O-methyl ether; (4)3 - p r e n y l - p-coumaric acid (drupanin); (5)3 , 5 - d i p r e n y lp-coumaric acid (artepillin C); (6) baccharin.Evidence-Based Complementary and Alternative Medicine 5
Table 3: Eﬀects of B. dracunculifolia extract (5–200mgkg−1)a n d
sulfasalazine (25mgkg−1) on GSH content, MPO activity and AP
activity in TNBS acute colitis
Group GSH content
(nmol g−1 tissue)
MPO activity
(Ug−1 tissue)
AP activity
(mU mg−1
protein)
Non-colitic 1357.5±86.5∗∗ 84.2±8.7∗∗ 6.24±0.36∗
TNBS control 759.6±31.9 684.2±62.8 12.62±1.72
B. dracunculifolia
5mgkg −1 967.3±55.0∗ 324.9±89.9∗∗ 10.53±1.21
10mgkg−1 850.3±27.8 532.8±96.3 14.58±1.36
25mgkg−1 878.5±82.7 576.4±79.8 14.27±2.02
50mgkg−1 809.4±55.0 216.9±31.6∗∗ 6.16±0.63∗
100 mg/kg−1 873.8±25.8 245.8±39.9∗∗ 7.45±0.93
200mgkg−1 930.9±113.8 380.1±84.4∗ 9.54±1.76
Sulfasalazine 1006.2±87.0∗ 419.8±80.1∗ 9.02±1.56
Dataareexpressedasmean±SEM. ∗P <.05, ∗∗P <.01versusTNBS control
group.
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Figure 2: HPLC proﬁle of B. dracunculifolia:( 1)c a ﬀeic acid;
(2) p-coumaric acid; (3) aromadendrin-4-O-methyl ether; (4)3 -
prenyl-p-coumaric acid (drupanin); (5)3 , 5 - d i p r e n y lp-coumaric
acid (artepillin C); (6) baccharin.
considerably increased in colonic biopsy specimens from
ulcerative colitis and Crohn’s disease patients in compari-
son with normal control mucosa, in a manner positively
correlated with inﬂammatory bowel disease activity. This
phenomenon appears to be neutrophil derived [35]. Thus,
antioxidant therapy can constitute an interesting approach
in the downregulation of this inﬂammatory condition. In
the context of this eﬀect, the beneﬁcial protection exerted by
the 5-aminosalicylic derivatives has been attributed to their
antioxidant and free radical scavenger properties [7]. Thus,
plant extracts containing antioxidant compounds such as
ﬂavonoids and other phenolic compounds may be of prime
interest [36].
The present study shows the preventive eﬀect exerted by
an ethyl acetate extract of B. dracunculifolia in ameliorating
the colonic insult induced after intracolonic administration
of TNBS to rats. The preventive intestinal anti-inﬂammatory
activity of this plant extract (5 and 50mgkg−1)w a s
evidenced macroscopically by reducing the damage score
of the lesions in the acute phase of the TNBS-induced
inﬂammatory process. Similar eﬀects were produced by oral
administration of 25mgkg−1 of sulfasalazine, a drug of
choice for treating IBD. Both B. dracunculifolia extract and
sulfasalazine failed to decrease the colonic weight/length
ratio. The lack of eﬀect on this ratio can be explained
by the severe and extensive colonic damage induced by
TNBS/ethanol, which is diﬃcult to overcome by pharma-
cological treatment as has been previously suggested [37].
I nt h ea c u t ep h a s eo ft h ec o l o n i ci n ﬂ a m m a t o r yp r o c e s s ,t h e
protective eﬀects of B. dracunculifolia extract were not dose
dependent, since higher doses of plant extract resulted in the
loss of activity. A dual eﬀect has already been described for
ﬂavonoids, such as diosmin and hesperidin [38], quercetin
[33]a n ds i l y m a r i n[ 39], isocoumarin paepalantine [10]a s
well as coumarin and 4-hydroxycoumarin [11], and may
be related to the known capacity of these compounds to
behave as antioxidants at lower doses and pro-oxidants at
high doses in rat colon. On the other hand, inﬂammation is
a multicomponent system that involves a network of cellular
crosstalk and control. However, the anti-inﬂammatory eﬀect
produced by B. dracunculifolia may be related to distinct
mechanisms of these compounds acting on distinct inﬂam-
matory mediators.
MPOactivity hasbeenwidelyused todetectandmonitor
intestinal inﬂammation, so that a reduction in the activity
of this enzyme can be interpreted as a manifestation of the
anti-inﬂammatory property of a given compound [36, 40].
Similarly, AP activity can also be considered as a sensitive
marker of inﬂammation in the intestine, since this enzyme’s
activity is invariably augmented in experimental conditions
[32, 41]. One of these mechanisms could be the antioxidant
properties of B. dracunculifolia extract. This property may
play a crucial role in the intestinal anti-inﬂammatory eﬀect
of the plant extract, given that intense oxidative insult is a
common feature in human IBD [42, 43]a n di nt h ed i ﬀerent
experimental models of rat colitis including TNBS [32, 44,
45]. In this aspect, in the present study, B. dracunculifolia
extract treatment of TNBS colitic rats counteracted the
depletionofcolonicglutathionelevelsthattookplacein con-
trolcoliticanimalsinbothexperimentaltreatmentprotocols.
The eﬀect exerted by B. dracunculifolia extract in preserving
the colonic mucosa from oxidative insult may collaborate to
decreasetheneutrophilinﬁltration thatoccursin response to
TNBS. Free radical generation has been proposed as playing
an important early role in the pathogenesis of IBD [6], and
could contribute to the initial neutrophil inﬁltration in the
inﬂamed colonic mucosa. The recruitment and activation of
these cellsresult in an increase infree radical productionthat
overwhelms the tissue’s antioxidant protective mechanisms,
resulting in a situation of oxidative stress, which deﬁnitively
perpetuates colonic inﬂammation [42]. As a consequence, a
rapid inhibition of free radical generation could contribute6 Evidence-Based Complementary and Alternative Medicine
Table 4: Eﬀects of B. dracunculifolia extract (5 and 50mgkg−1) and sulfasalazine (25mgkg−1) on damage score, changes in colonic
weight/length, diarrhea and adherence incidence in TNBS chronic colitis with relapse
Group Damage scorea
(0–10)
Colonic
weight/lenghtb
(mg cm−1)
Diarrhoea (%) Adherence (%)
1 week
Non-colitic 0∗∗∗ 100.57±8.03∗∗ 0∗ 0∗
TNBS-control 8.0 (7–9) 276.10±31.17 83.3 83.3
B. dracunculifolia 5mgkg −1 2.0 (0–4)∗ 140.53±8.61∗∗ 0∗ 0∗
B. dracunculifolia 50mgkg−1 1.0 (0–5)∗ 171.00±22.91∗∗ 33.3 33.3
Sulfasalazine25mgkg−1 3.5 (2–7) 143.25±20.56∗∗ 0 50.0
2 week
Non-colitic 0∗∗∗ 87.16±4.32∗∗ 00 ∗∗
TNBS-control 2.5 (2–3) 185.40±22.21 16.7 100.0
B. dracunculifolia 5mgkg −1 3.0 (0–4) 117.50±6.45∗∗ 0 16.7∗
B. dracunculifolia 50mgkg−1 4.0 (2–5) 141.90±12.02 33.3 33.3
Sulfasalazine25mgkg−1 4.0 (1–6) 137.95±10.73 0 33.3
aScore data are expressed as median (range).
bColonic weight data are expressed as mean±SEM.
∗P < .05, ∗∗P < .01, ∗∗∗P < .001 versus TNBS control group.
Table 5:Eﬀects ofB.dracunculifolia extract (5and50mgkg−1)andsulfasalazine(25mgkg−1)onGSHcontent,MPOactivityandAPactivity
in TNBS chronic colitis with relapse
Group GSH content
(nmolg−1 tissue)
MPO activity
(Ug−1 tissue)
AP activity
(mUmg−1 protein)
1 week
Non-colitic 2357.6±311.3∗ 127.6±14.5∗∗ 4.20±0.36∗∗
TNBS control 1590.1±53.6 1045.2±231.2 19.15±4.38
B. dracunculifolia 5mgkg −1 2386.1±177.1∗ 221.1±59.2∗ 7.93±1.13∗∗
B. dracunculifolia 50mgkg−1 2218.6±97.4∗ 167.6±12.7∗ 8.31±1.51∗∗
Sulfasalazine25mgkg−1 1992.2±254.2 951.0±328.0 7.45±0.92∗∗
2 week
Non-colitic 2233.9±192.5 115.9±12.9 5.79±0.70∗∗
TNBS control 1881.3±146.8 220.6±42.9 13.31±1.65
B. dracunculifolia 5mgkg −1 2228.3±132.7∗ 167.5±31.7 8.39±1.07∗
B. dracunculifolia 50mgkg−1 2538.2±132.8∗∗ 178.5±34.6 8.78±1.13∗
Sulfasalazine25mgkg−1 1776.6±63.5 262.4±59.4 11.20±1.29
Data are expressed as mean±SEM.
∗P < .05, ∗∗P < .01 versus TNBS control group.
to a lower level of leukocyte inﬁltration into the inﬂamed
tissue, thus preventing colonic tissue becoming inﬂamed.
The antioxidant properties ascribed to this B. dracunculi-
folia extract could also contribute to its intestinal anti-
inﬂammatory eﬀect, similarly to other reputed drugs used in
thetreatment ofIBD,such as 5-aminosalicylic derivates [46],
thus supporting additional studies aiming to evaluate the
application of this plant extract in the treatment of human
IBD.
In the second set of experiments, the eﬀects of B.
dracunculifolia were evaluated after induction of the inﬂam-
matory process. The results demonstrated that oral admin-
istration of B. dracunculifolia extract (5 and 50mgkg−1)
after colitis induction signiﬁcantly reduced the macroscopic
colonic damage score and lesion extension after the ﬁrst
week when compared to the corresponding TNBS control
group. In addition, these compounds were able to alter
the extent of neutrophil inﬁltration into the colon 1 week
after TNBS administration, as determined by tissue MPO
activity reduction. The reduction of neutrophil inﬁltration
seemed to be a consequence of the accelerated healing of
colonic ulcers, thus facilitating the elimination of neutrophil
accumulationfromtheinﬂamed colon.Similarly totheacute
experimental setting, the anti-inﬂammatory eﬀect exerted
by B. dracunculifolia extract at doses of 5 and 50mgkg−1
in chronic colitis was related to the protective eﬀect againstEvidence-Based Complementary and Alternative Medicine 7
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Figure 3:Maineﬀects oftheB. dracunculifolia ontheinﬂammatory
intestinal process induced by TNBS in rats. Black lines indicate
inhibition and black arrows indicate counteraction of depletion
induced by the inﬂammatory process.
GSH depletion and inhibition of AP activities in the ﬁrst and
second week.
HPLC analysis of the ethyl acetate extract of B. dracun-
culifolia permitted the identiﬁcation of such cinnamic acid
derivatives such as caﬀeic, p-coumaric, 3-prenyl-p-coumaric
(drupanin), 3,5-diprenyl-p-coumaric (artepillin C) and 3-
prenyl-4-dihydrocinnamoiloxy–cinnamic (baccharin) acids,
as well as the ﬂavonoid aromadendrin-4-O-methyl ether
(Figure 2) .A r t e p i l l i nCw a sd e t e c t e da sam a j o rc o m p o n e n t
of B. dracunculifolia. This compound is also the main con-
stituent in Brazilian green propolis and an eﬃcient radical
scavenger [21]. Artepillin C is a potent anti-inﬂammatory
compound that decreases the number of neutrophils during
peritonitis and reduces the prostaglandin E2 level, nitric
oxide production and NF-κBa c t i v i t y[ 22]. In addition,
artepillin C also suppresses the formation of aberrant crypt
foci induced by azoxymethane in mouse colon after oral
administration [47]. Phenolic compounds including cin-
namic acid derivatives detected in B. dracunculifolia extract
have been identiﬁed as responsible for antiulcerogenic [18],
immunomodulatory [21], antitumoural [48, 49], neuro-
protective and antioxidant [23, 50] activities. Polyphenolic
compounds of higher plants are known to be excellent
in vitro antioxidants, while numerous studies suggest that
dietary intakeofplantphenolicsmay producepositive eﬀects
on oxidative stress-related diseases [51]. The compounds of
B. dracunculifolia presented free radical scavenging activity
similar to that of green propolis, and phenolic compounds
are found abundantly in both [52].
In conclusion, the present study showed that B. dracun-
culifolia prevents colonic damage induced by TNBS in rats
with either acute or chronic colitis. This anti-inﬂammatory
eﬀect may be associated with improved intestinal oxidative
stress (Figure 3), mainly due to reduced MPO activity,
augmentedendogenousantioxidantdefencesin theinﬂamed
colon, such as glutathione content and inhibited lipid
peroxidation. This intestinal anti-inﬂammatory activity is
related to the phenolic compounds present in the plant
extract, mainly artepillin C. In this manner, the use of B.
dracunculifolia, the main source of active compounds in
Brazilian green propolis, as a dietary product, can be an
important supplement in the treatment and prevention of
human IBD.
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